Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-07 Sale |
2025-04-08 5:01 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
3,678 | $4.5513 | $16,740 | 91,779 (Indirect Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 4:24 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
6,583 | $6.5883 | $43,371 | 95,457 (Indirect Direct) |
View |
| 2024-12-19 Sale |
2024-12-20 4:20 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
1,291 | $8 | $10,328 | 100,067 (Indirect Direct) |
View |
| 2024-07-15 Sale |
2024-07-17 2:51 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
4,325 | $11.72 | $50,689 | 101,358 (Indirect Direct) |
View |
| 2024-04-08 Sale |
2024-04-10 4:30 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
3,435 | $11.1 | $38,129 | 97,174 (Indirect Direct) |
View |
| 2024-01-19 Sale |
2024-01-22 8:22 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
6,307 | $7.7533 | $48,900 | 220,609 (Indirect Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:40 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
2,127 | $7.2415 | $15,403 | 104,195 (Indirect Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 4:55 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
12,492 | $8.8753 | $110,871 | 106,322 (Indirect Direct) |
View |
| 2023-06-02 Sale |
2023-06-05 6:32 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
1,960 | $11.41 | $22,368 | 68,845 (Indirect Direct) |
View |
| 2023-05-22 Sale |
2023-05-23 12:15 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
2,110 | $12.87 | $27,165 | 70,805 (Indirect Direct) |
View |
| 2023-04-06 Sale |
2023-04-07 3:18 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
3,439 | $7.27 | $25,002 | 72,915 (Indirect Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:03 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
2,032 | $8.5309 | $17,335 | 76,354 (Indirect Direct) |
View |
| 2022-11-21 Sale |
2022-11-23 4:10 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
2,159 | $9.6 | $20,726 | 43,680 (Indirect Direct) |
View |
| 2022-05-13 Purchase |
2022-05-16 8:43 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
6,000 | $0 | $0 | 26,000 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:34 pm |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
331 | $7.58 | $2,509 | 44,082 (Direct) |
View |
| 2021-11-30 Sale |
2021-12-02 1:15 pm |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
2,587 | $12.03 | $31,122 | 14,913 (Direct) |
View |
| 2021-05-17 Purchase |
2021-05-18 11:36 am |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
2,500 | $15.85 | $39,625 | 2,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-27 Option Award |
2025-03-03 5:15 pm |
N/A 2035-02-26 |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
122,000 | $0 | 217,457 (Direct) |
View |
| 2024-05-31 Option Award |
2024-05-31 6:37 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
7,500 | $0 | 104,674 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 8:22 pm |
N/A 2034-01-17 |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
120,000 | $0 | 220,609 (Direct) |
View |
| 2023-11-01 Option Award |
2023-11-03 4:55 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
22,500 | $0 | 106,322 (Direct) |
View |
| 2023-07-14 Option Award(A) |
2023-07-21 8:30 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
25,000 | $0 | 95,180 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-17 5:00 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
25,000 | $1 | 96,314 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-20 7:32 pm |
N/A 2033-01-18 |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
88,000 | $0 | 133,386 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
7,500 | $0 | 45,839 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:17 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
12,000 | $0 | 38,000 (Direct) |
View |
| 2022-04-05 Option Award |
2022-04-06 8:50 pm |
N/A 2032-04-04 |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 4:34 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
666 | $0 | 44,082 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:34 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
37,500 | $0 | 44,082 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 1:15 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
5,000 | $0 | 14,913 (Direct) |
View |
| 2021-06-05 Option Award |
2021-06-08 2:33 pm |
N/A 2031-05-31 |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 3:57 pm |
N/A 2031-01-30 |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 4:37 pm |
N/A 2030-09-30 |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | Henderson Molly Executive Vice President & CFO |
50,000 | $0 | 50,000 (Direct) |
View |